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appropriate antibiotic for empiric therapy. Further studies
are necessary to further determine the risk of Bacillus cereus
infection.
doi:10.1016/j.ijid.2010.02.484388 14
Conclusion: The results of the study suggest the pos-
ibility of co-infections with several genospecies of B.
urgdorferi s.l. evidenced by the presence of IgM antibod-
es to OspC of B. burgdorferi s.s., B. afzelii, B. garinii, and
. spielmanii. The detection of antibodies directed against
peciﬁc B. spielmanii antigens suggests that this microorgan-
sm may be responsible for triggering borreliosis both as a
ingle etiologic agent and in co-infection with other Borrelia
enospecies.
oi:10.1016/j.ijid.2010.02.482
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xperience along 17 years
.A. Pensotti 1,∗, F. Nacinovich2, C. Di Stéfano3, J. Thierer4,
. Ferraris 5, D. Stamboulian6
FUNCEI and Clinica Privada Monte Grande, Ciudad
utonoma de Buenos Aires, Argentina
FUNCEI and ICBA, Buenos Aires, Argentina
FUNCEI, Ciudad Autonoma de Buenos Aires, Argentina
ICBA, Ciudad Autonoma de Buenos Aires, Argentina
FUNCEI, Ciudad Autónoma de Buenos Aires, Argentina
Clinical Director of FUNCEI, Ciudad Autonoma de Buenos
ires, Argentina
Background: Enterococcal bone and joint infections
EBJI) are an uncommon disease and the optimal treatment
nd outcome have been poorly deﬁned. The objective was
o analize the outcome of EBJI episodes (ep.) according
o patients’ characteristics and microbiological features,
onsidering type of surgery implemented and antibiotic
reatment chosen.
Methods: We performed a retrospective cohort study of
atients with EBJI, treated by our working group from 1/91
o 3/09. Categorical variables are presented as percentages
nd continuous variables as median and interquartile range
IQR). Differences were considered statistically signiﬁcant
t p <= 0.05.
Results: We evaluated 35 EBJI ep. occurred in 34 patients
ccounting for 3.3% of all BJI (35/1071) seen in the period
onsidered. Median age 63 years old (range IQR 40-72), 63%
emale patients. Comorbidities (diabetes, peripheral vas-
ular disease, cancer) were found in 31.4%. Twenty eight
p. (80%) were implants associated infections (IAI) (15
rosthetic joint, 13 fractures with internal ﬁxation) and 7
20%) osteomyelitis (OM; 86% chronic). Five ep. (14.3%) had
olymicrobial cultures (4 P. aeruginosa, 1 MRSA). All patients
eceive antibiotic therapy (35 aminopenicillins, 5 glycopep-
ides, 1 carbapenems) during a median of 13 weeks (IQR
-24); 13 (37,1%) were treated with combined aminogly-
osides and 22 (62,8%) without them. Fifteen ep. (42,8%)
nderwent prolongued suppressive therapy for a median of
6 weeks (IQR 4-32). Surgery was performed in 19 ep. (67,8%)
f IAI (52,6% with debridement and retention of the implant)
nd 4 ep. (57,1%) of osteomyelitis. Follow up: 15 months
median; IQR 10-24). The overall outcome was favorable in
0 ep. (85,7%); there were 5 relapses (14,3%) and no failures.
sing an univariated analysis, we evaluated the outcome
ccording this variables: age, gender, comorbidities, micro-
iology, implant, surgery performed and its modality, use ofternational Congress on Infectious Diseases (ICID) Abstracts
minoglycosides and length of antibiotic treatment. None of
hem were related to a better or worse outcome.
Conclusion: EBJI are an uncommon disease mostly asso-
iated to implants. Treatment must include surgery and
ntibiotics. In our series, outcome was not modify by
atients’ caractheristics, presence of an implant, type of
urgery performed, lenght of antibiotic treatment and use
f combined therapy with aminoglycosides.
oi:10.1016/j.ijid.2010.02.483
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Background: Since Bacillus cereus is rarely associated
ctual infections, single positive blood culture is often con-
idered as contamination. However, it can cause number
f nosocomial infections such as catheter-associated blood
tream infection. We investigated the bacteremic patients
o assess the clinical impact of this organism.
Methods:We performed a retrospective analysis of blood-
tream infections due to B. cereus at a tertiary care hospital
n Kobe, Japan from October 2008 to September 2009. Cases
ere identiﬁed via microbiology laboratory reports, and
elevant clinical data were collected from the electronic
edical record of each patient. The case with at least 2 set
ositive blood cultures were deﬁned as real infection.
Results: Nine cases of catheter related blood stream
nfections (CRBSI) caused by B. cereus were identiﬁed. Only
ne case had the presence of an indwelling central venous
atheter (CVC). Three cases (33%) were associated with
revious antibiotic therapy. Two cases (2/9, 22%) were asso-
iated with solid organ malignancies whereas no case with
ematological malignancy. One patient was on continuous
emodialysis. The most common characteristics (7/9, 77%)
ere the use of peripheral parenteral nutrition. These 7
ases had use of solutions containing 7.5% glucose and 3.0%
mino acid. For 8 cases vancomycin was used with success.
o patient died. All isolates were sensitive for vancomycin
hereas resistant to beta-lactams. Two isolates were sensi-
ive for clindamycin.
Conclusion: Bacillus cereus can cause CRBSI. Indwelling
VC may not increase Bacillus cereus CRBSI whereas
eripheral parenteral nutrition with higher amino acid
oncentration can be a risk factor. Vancomycin may be
